Global B2B Pharmaceutical Marketplace Β· Sourcing Β· Named-Patient Access
πŸ’¬ WhatsApp Β· Sign in Β· Register

Cold Chain & Temperature-Controlled Logistics

GDP-compliant shipping for temperature-sensitive pharmaceuticals β€” qualified packaging, continuous monitoring, and a documented excursion procedure so a delay at customs does not become a written-off consignment.

Mitul Agarwal
Written by Mitul Agarwal Β· B.Pharm, MBA
Founder & Head of Business Development Β· 25+ years in international pharmaceutical BD&L

Cold chain rarely fails in the air. It fails on the ground.

In our experience the flight is almost never the problem. Temperature excursions happen on the apron waiting for a transfer, in an unrefrigerated customs warehouse while a document is queried, and on the final road leg to a hospital or depot where nobody had arranged a refrigerated vehicle.

That is why the packaging qualification and the customs plan have to be designed together. A shipper qualified for 72 hours is worthless on a lane where clearance routinely takes five days. We size the thermal protection against the realistic worst case for that specific route, including the clearance step, not against the scheduled transit time.

And because excursions still occasionally happen, we agree in advance who assesses the data and on what basis the goods are released or rejected. Deciding that after the event is how disputes start.

Where excursions occur
  • Apron and tarmac waiting time between connections
  • Non-refrigerated customs bond while paperwork is queried
  • Weekend and public-holiday clearance gaps
  • Final road leg without a refrigerated vehicle
  • Receiving site with no cold storage capacity at delivery
  • Packaging qualified for a shorter duration than the real lane time

Temperature ranges we handle

2–8°C
Refrigerated

Vaccines, insulins, biologics, monoclonal antibodies, many injectables and reference biologics.

15–25°C
Controlled room temperature

Products with an upper limit that summer transit through the Gulf, South Asia or Africa will breach without protection.

−20°C
Frozen

Certain biologics, plasma-derived products and study material requiring frozen distribution.

≤−70°C
Deep frozen

Dry-ice or cryogenic shipping for specific biologics and advanced therapy material, subject to route feasibility.

Feasibility on deep-frozen and cryogenic lanes depends heavily on carrier capability and destination handling. We confirm the route is genuinely viable before accepting the shipment.

What the service includes

  • Qualified passive shippers or active containers, sized to the real lane duration
  • Continuous electronic data logger in every temperature-controlled consignment
  • Pre-conditioned coolants and validated pack-out procedure
  • Lane risk assessment covering season, transit and clearance time
  • Carrier selection based on cold-chain handling capability, not lowest freight rate
  • Pre-alert documentation so customs has papers before the goods land
  • Cold storage at transit points where clearance may extend
  • Refrigerated final-mile vehicle to depot, hospital or site
  • Temperature record supplied on delivery for QA review before release
  • Pre-agreed excursion assessment and release-or-reject procedure

How we plan a temperature-controlled shipment

1
Product and storage condition

Label storage condition, permitted excursion tolerance if any, and stability data supporting it. The label condition alone is not enough to plan a lane.

2
Lane risk assessment

Origin and destination ambient conditions in that season, realistic clearance time on that route, number of transfers, and availability of cold storage at each hold point.

3
Packaging selection and qualification

Shipper chosen with headroom over the assessed worst case, and the pack-out procedure documented so it is reproducible on repeat shipments.

4
Documentation ahead of the goods

Import permit, CoA, invoice and packing list submitted as a pre-alert. Most cold-chain losses we have seen trace back to a document query, not a packaging failure.

5
Transit with monitoring

Continuous logging throughout, with milestone tracking at departure, transfer, arrival and clearance so a delay is visible while it can still be acted on.

6
Delivery and data review

Refrigerated final mile, receipt into cold storage, and the full temperature record handed over so your QA makes the release decision on evidence.

If an excursion happens

No honest logistics provider will promise excursions never occur. What matters is what happens next, and that it is agreed before the shipment moves rather than argued afterwards.

1. Quarantine, don't discard

Goods go into quarantine on arrival, not into use and not into the bin. The decision is a quality decision, not a commercial one.

2. Assess against stability data

The logger record is assessed against the product's stability data and any permitted excursion allowance. Some products tolerate a defined deviation; others do not.

3. Documented outcome

Release or reject is recorded with the reasoning, so your QA file is complete and any insurance or replacement claim has evidence behind it.

Liability, insurance cover and replacement terms are set out in the shipment contract. We recommend appropriate cargo insurance on every temperature-controlled consignment and will say so even where it is not required.

Have a temperature-sensitive shipment to plan?

Tell us the product, storage condition, quantity, origin and destination. We will assess the lane and tell you honestly whether it is viable before you commit stock to it.

Submit Shipment Requirement Ask about a route

Frequently Asked Questions

Good Distribution Practice is the set of standards covering how medicines are stored, transported and handled once they leave the manufacturing site, so that quality and integrity are maintained through to the point of delivery. In practice it means qualified storage, temperature monitoring and control, traceability of every movement, trained personnel, and documented procedures for deviations. Many regulators and institutional buyers require GDP compliance from anyone in the distribution chain.

Not usually in the air. The common failure points are waiting time on the apron between connections, non-refrigerated customs warehousing while a document is queried, weekend and holiday clearance gaps, and a final road leg where no refrigerated vehicle was arranged. This is why packaging must be qualified against realistic lane duration including clearance, and why documentation should reach customs before the goods do.

Yes. Every temperature-controlled consignment carries a continuous electronic data logger, and the full record is supplied on delivery so your quality team can review it and make the release decision before the goods are used. Real-time monitoring is available on lanes and consignments where it is justified.

The consignment is quarantined rather than used or discarded, the logger record is assessed against the product's stability data and any permitted excursion allowance, and the release-or-reject outcome is documented with its reasoning. Because that assessment basis is agreed before the shipment moves, there is no dispute afterwards about who decides or on what grounds.

Yes, subject to route feasibility and the destination's import requirements. The practical constraints are usually carrier cold-chain capability on that lane, availability of refrigerated storage at the arrival airport if clearance extends, and whether the receiving site can accept and store the goods on arrival. We check all three before accepting the shipment rather than after.

Insurance cover depends on the agreed Incoterm and the shipment contract. We recommend appropriate cargo insurance on every temperature-controlled consignment given the value at risk, and we will raise it even where the terms do not require us to. Cover, limits and claim procedure are confirmed in writing before dispatch.

Yes, and it is more often overlooked than 2 to 8 degree shipping. A product labelled for storage below 25 or 30 degrees will breach that limit in an unprotected consignment moving through the Gulf, South Asia or sub-Saharan Africa in summer. These lanes need thermal protection and a seasonal risk assessment even though the product is not technically cold chain.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.